|
Market Cap (5-Jun) $18,417,672 (949th) |
Close (30-Jun) $0.005 |
Volume (30-Jun) 14,697,042 |
Shortsold (2-Apr) 218 (0.00%) (630th) |
|
52w High $9.00 |
52w Low $0.300 |
P/E 14.90 |
EPS -3.21 |
MXC released this announcement to the ASX on 8 July 2022, 9:59. The announcement is marked as price sensitive, and is 4 page(s) in length and 249.52kb in size.
You can view all announcements from MXC and see how they appear on a price chart on the announcements page.
At the date of this announcement, MXC was 0.010% short sold according to ASIC data. It was ranked the 640th most shorted stock on the ASX. It is now ranked as the 630th most shorted stock on the ASX with 0.000% of total shares short sold as of the latest reported data (02 April 2024).
| Other Recent Announcements from MXC | |
|---|---|
| Details of Company Address | 30 June 2023, 17:34 |
| Company Update | 30 June 2023, 17:24 |
| Results of Meeting | 29 June 2023, 18:43 |
| Approvals received for South African CimetrA Clinical Trial | 8 July 2022, 9:59 |
| Launch of Medical Data Collection App - ZAM | 6 July 2022, 17:58 |
| CimetrA anti-inflammatory pre-clinical study results | 27 June 2022, 11:27 |
| US Market Update - CimetrA Clinical Trial Progress | 24 June 2022, 14:32 |
You must be logged in to post a reply.
MGC Pharmaceuticals 